Corporate Venture Capital

Sosei Corporate Venture Capital (“Sosei CVC”) was established in June 2016 to invest primarily in Japanese biotechnology companies specialized in life science related to regenerative medicine. Sosei Group Corporation has a 90% stake in Sosei CVC.